1H9U

The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268

1H9U の概要

• エントリーDOI: 10.2210/pdb1h9u/pdb
• 分子名称: RETINOID X RECEPTOR, BETA, 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE-3-CARBOXYLIC ACID, NICKEL (II) ION, ... (5 entities in total)
• 機能のキーワード: nuclear receptor, rxr, transcription factor
• 由来する生物種: HOMO SAPIENS
• 細胞内の位置: Nucleus: P28702
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 101130.23

構造登録者

Schwabe, J.W.R.,Love, J.D.,Gooch, J.T. (登録日: 2001-03-21, 公開日: 2002-04-03, 最終更新日: 2023-12-13)

主引用文献

Love, J.D.,Gooch, J.T.,Benko, S.,Li, C.,Nagy, L.,Chatterjee, V.K.K.,Evans, R.M.,Schwabe, J.W.R.
The Structural Basis for the Specificity of Retinoid-X Receptor-Selective Agonists: New Insights Into the Role of Helix H12
J.Biol.Chem., 277:11385-, 2002

PubMed Abstract: Ligands that specifically target retinoid-X receptors (RXRs) are emerging as potentially powerful therapies for cancer, diabetes, and the lowering of circulatory cholesterol. To date, RXR has only been crystallized in the absence of ligand or with the promiscuous ligand 9-cis retinoic acid, which also activates retinoic acid receptors. Here we present the structure of hRXRbeta in complex with the RXR-specific agonist LG100268 (LG268). The structure clearly reveals why LG268 is specific for the RXR ligand binding pocket and will not activate retinoic acid receptors. Intriguingly, in the crystals, the C-terminal "activation" helix (AF-2/helix H12) is trapped in a novel position not seen in other nuclear receptor structures such that it does not cap the ligand binding cavity. Mammalian two-hybrid assays indicate that LG268 is unable to release co-repressors from RXR unless co-activators are also present. Together these findings suggest that RXR ligands may be inefficient at repositioning helix H12.

PubMed: 11782480
DOI: 10.1074/JBC.M110869200

実験手法

X-RAY DIFFRACTION (2.7 Å)